Dublin, May 07, 2025 (GLOBE NEWSWIRE) -- The "Plant Biotechnology Market by Product Type (Crop Protection & Nutrition Solution Products, Biotech Seed & Traits, Synthetic Biology Enabled Products), Technology Type, Crop Type, End User, and Region - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering.
The global plant biotechnology market is anticipated to reach USD 76.79 billion by 2030, up from USD 51.73 billion in 2025, reflecting a CAGR of 8.2%
This growth is propelled by the increasing global demand for sustainable food production, climate-resilient crops, and innovative biopharmaceutical solutions. Emphasizing genetic engineering and tissue culture techniques, the market has flourished due to advancements in CRISPR-Cas9 technology, substantial investments, and the urgent need to address food security amid population growth.
Disruptions in the market arise from the increasing seed replacement rate, high adoption of biotech crops, growing demand for high-value crops, and the use of plant growth regulators amidst climatic shifts. Biotechnology boosts agricultural productivity and quality, heightening global farmers' income and decreasing reliance on chemical pesticides.
Biofertilizers in Biopesticides Segment
Biofertilizers are gaining traction due to their eco-friendly nature and ability to enhance soil fertility. Utilized in hydroponics and controlled environment agriculture, these microbial components are favored over chemical fertilizers. Recent innovations in nanotechnology have furthered biofertilizer development by improving nutrient delivery and reducing environmental impact. The shift towards scientific scrutiny has increased R&D investments, as evidenced by the Danish innovation, Bluubalance, which enhances yield and reduces carbon waste. Biofertilizers are integral to sustainable agriculture, supporting plant health and environmental sustainability.
Pharmaceutical and Biopharma Industry Growth
The pharmaceutical sector is increasingly utilizing plant biotechnology for developing vaccines, bioactive compounds, and genetically engineered medicinal plants. Plants like tobacco and rice are engineered for therapeutic protein production. Companies such as Medicago and Protalix BioTherapeutics are pioneers in plant-made pharmaceuticals. The growing demand for cost-effective and scalable plant-based biologics broadens treatment avenues for diseases, accelerating drug production and enhancing healthcare accessibility globally.
Europe's Pivotal Role
Europe leads in plant biotechnology, characterized by scientific innovation, robust regulatory frameworks, and dedication to sustainable agriculture. Prominent research institutions like Germany's Max Planck Institute and the Netherlands' Wageningen University spearhead advancements in crop development and sustainability. Europe's distinctive approach combines cutting-edge research and ecological stewardship, positioning it at the forefront of agricultural innovation.
Industry Insights
Interviews with industry leaders reveal significant insights by company type (Tier 1: 25%, Tier 2: 45%, Tier 3: 30%) and region (Europe: 30%, North America: 25%). Key players include BASF SE, Bayer AG, and Corteva Agriscience. These companies are at the forefront of plant biotechnology, driving advancements through strategic partnerships, research investments, and innovative product launches.
Research Coverage
The report offers a comprehensive categorization of the plant biotechnology market by technology type, crop type, product, end-user, and region. Detailed analysis highlights the major forces influencing market growth: drivers, such as rising demand for high-value crops; restraints, including lengthy approval periods; and opportunities, like public-private partnerships. It evaluates key players' strategies, new product developments, and market opportunities, equipping stakeholders with insights to navigate the competitive landscape effectively.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 469 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value (USD) in 2025 | $51.73 Billion |
| Forecasted Market Value (USD) by 2030 | $76.79 Billion |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | Global |
Market Dynamics
Drivers
- Rise in Seed Replacement Rate
- High Adoption of Biotech Crops
- Growing Demand for High-Value Crops
- Use of Plant Biotechnology to Combat Climatic Changes
Restraints
- Long Approval Period for New Products
- High R&D Expenses on Quality Biotech Seed Development
Opportunities
- Public-Private Partnerships in Varietal Seed Development
- Increasing Use of Molecular Breeding Technology
- Increased Production and Yield of Crops
Challenges
- Unorganized New Entrants with Low Profit-To-Cost Ratio
- Lack of Availability and Access to High-Quality Plant Biotechnology Products
Case Study Analysis
- Avalo's AI-Powered Crop Breeding: Accelerating Climate-Resilient Agriculture
- Accelerating CRISPR Applications in Crop Breeding and Optimizing Yield
Company Profiles
- BASF SE
- Bayer AG
- Corteva Agriscience
- Syngenta
- Kws Saat SE & Co. KGaA
- Upl
- Fmc Corporation
- Sumitomo Chemical Co. Ltd.
- Nufarm
- Pro Farm Group
- Limagrain
- Stk Bio-AG Technologies
- Certis Biologicals
- Dlf Seeds A/S
- Vestaron Corporation
- Rovensa Next
- Ipl Biologicals
- Lallemand Inc.
- Rizobacter Argentina SA
- Enza Zaden Beheer B.V.
- Genica
- Kay Bee Bio Organics Pvt. Ltd.
- Verdesian Life Sciences
- Botanohealth
- Axeb Biotech
For more information about this report visit https://www.researchandmarkets.com/r/th99p2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
